In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008.
about
Post weaning diarrhea in pigs: risk factors and non-colistin-based control strategiesIncrease of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.Polymyxin-resistant clinical isolates of Escherichia coli.Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Dosing of colistin-back to basic PK/PD.Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period.Multidrug-resistant Gram-negative infections: the use of colistin.When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran.Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015.Draft genome sequence of Paenibacillus polymyxa OSY-DF, which coproduces a lantibiotic, paenibacillin, and polymyxin E1.A Dual Role of P53 in Regulating Colistin-Induced Autophagy in PC-12 Cells.
P2860
Q30376918-8DBCD667-89E8-4696-8A62-D22A9DBD08C8Q33705711-A1ABB233-0923-498E-9FAF-856786B8301AQ34483666-85D7973B-C69F-46F6-8F65-46777F8B4936Q34552966-7A97B5FB-0DE7-42A0-83C7-EC762EDB0C5BQ35242165-365063F9-83AD-44AB-B77E-6D7002972612Q35796552-E3C50113-89BF-405D-84EA-1FA780CD942FQ37785545-103F177A-72B9-4A16-8CC7-061E3C5F2DAAQ37907967-D8A9CFFF-FF1E-4634-9404-4DC8072219C1Q38097120-FB37604D-F884-40EF-9A50-D6DE32998C5CQ38416932-0A9495E6-9B67-4713-BFE1-744D209ADB65Q40726963-DE6B02F8-F5AC-43AD-BEDA-C35175815A82Q40789035-7DB9B9C2-8E8C-4F55-98B2-5C1FA8E67B98Q42268915-BAE689E6-9056-4E29-AA09-C0C372C3991BQ47101924-2A1657F1-F594-493D-A784-7CA77B4A12D8
P2860
In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@en
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@nl
type
label
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@en
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@nl
prefLabel
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@en
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@nl
P2093
P2860
P356
P1476
In vitro activity of colistin ...... the CANWARD study, 2007-2008.
@en
P2093
P2860
P304
P356
10.1128/AAC.00786-09
P407
P577
2009-08-24T00:00:00Z